Alyeska Investment Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100,000
| Closed | -$17.2M | – | 811 |
|
|
2021
Q3 | $17.2M | Buy |
100,000
+50,000
| +100% | +$8.61M | 0.21% | 129 |
|
|
2021
Q2 | $6.28M | Sell |
50,000
-423
| -0.8% | -$53.1K | 0.07% | 295 |
|
|
2021
Q1 | $6.84M | Buy |
+50,423
| New | +$6.84M | 0.09% | 262 |
|
|
2017
Q4 | – | Sell |
-75,000
| Closed | -$2.8M | – | 524 |
|
|
2017
Q3 | $2.8M | Buy |
+75,000
| New | +$2.8M | 0.02% | 310 |
|
|
2016
Q2 | – | Sell |
-60,000
| Closed | -$1.58M | – | 509 |
|
|
2016
Q1 | $1.58M | Buy |
+60,000
| New | +$1.58M | 0.01% | 339 |
|
|
2013
Q4 | – | Sell |
-70,000
| Closed | -$1.56M | – | 346 |
|
|
2013
Q3 | $1.56M | Buy |
+70,000
| New | +$1.56M | 0.06% | 201 |
|